Tom Stoppard’s final play, which cost Writers Theatre more than $1 million to produce, is under the careful direction of the late playwright’s frequent collaborator Carey Perloff.
Carey Perloff, a director whose family background echoes that of playwright Tom Stoppard, is uniquely qualified to direct his ...
Studies of obinutuzumab, a type II anti-CD20 antibody, have shown efficacy in the treatment of hematologic cancers and autoimmune diseases. An evaluation of the efficacy and safety of obinutuzumab in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results